Expression of MHC class II in T cells is associated with increased HIV-1 expression
dc.contributor.author | Saifuddin, M. | en_US |
dc.contributor.author | Spear, G. T. | en_US |
dc.contributor.author | Chang, C. -H. | en_US |
dc.contributor.author | Roebuck, K. A. | en_US |
dc.date.accessioned | 2010-06-01T22:07:19Z | |
dc.date.available | 2010-06-01T22:07:19Z | |
dc.date.issued | 2000-08 | en_US |
dc.identifier.citation | Saifuddin, M.; Spear, G. T.; Chang, C.-H.; Roebuck, K. A. (2000). "Expression of MHC class II in T cells is associated with increased HIV-1 expression." Clinical & Experimental Immunology 121(2): 324-331. <http://hdl.handle.net/2027.42/75144> | en_US |
dc.identifier.issn | 0009-9104 | en_US |
dc.identifier.issn | 1365-2249 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75144 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10931149&dopt=citation | en_US |
dc.format.extent | 123188 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | Blackwell Science Ltd | en_US |
dc.subject.other | MHC Class II | en_US |
dc.subject.other | CIITA | en_US |
dc.subject.other | T Cell Activation | en_US |
dc.subject.other | HIV-1 Transcription | en_US |
dc.title | Expression of MHC class II in T cells is associated with increased HIV-1 expression | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Immunology/Microbiology, Rush University, Chicago, IL, and | en_US |
dc.identifier.pmid | 10931149 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75144/1/j.1365-2249.2000.01290.x.pdf | |
dc.identifier.doi | 10.1046/j.1365-2249.2000.01290.x | en_US |
dc.identifier.source | Clinical & Experimental Immunology | en_US |
dc.identifier.citedreference | Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells. Science 1999; 286: 1353 7. | en_US |
dc.identifier.citedreference | Chun TW, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387: 183 8. | en_US |
dc.identifier.citedreference | Perelson AS, Neumann AU, Markowitz M et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996; 271: 1582 6. | en_US |
dc.identifier.citedreference | Finzi D & Silliciano RF. Viral dynamics in HIV-1 infection. Cell 1998; 93: 665 71. | en_US |
dc.identifier.citedreference | Ho DD, Neumann AU, Perelson AS et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123 6. | en_US |
dc.identifier.citedreference | Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117 22. | en_US |
dc.identifier.citedreference | Stevenson M, Stanwick TL, Dempsey MP et al. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990; 9: 1551 60. | en_US |
dc.identifier.citedreference | Wong JK, Hezareh M, Gunthard HF et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278: 1291 5. | en_US |
dc.identifier.citedreference | Zack JA, Arrigo SJ, Weitsman SR et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61: 213 22. | en_US |
dc.identifier.citedreference | Brown MF, Cook RG, Van M et al. Cloned human T cells synthesize Ia molecules and can function as antigen presenting cells. Hum Immunol 1984; 11: 219 28. | en_US |
dc.identifier.citedreference | Gerrard TL, Volkman DJ, Jurgensen CH et al. Activated human T cells can present denatured antigen. Hum Immunol 1986; 17: 416 25. | en_US |
dc.identifier.citedreference | Lanzavecchia A, Roosnek E, Gregory T et al. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 1988; 334: 530 2. | en_US |
dc.identifier.citedreference | Brick-Ghannam C, Huang FL, Temime N et al. Protein kinase C (PKC) activation via human leucocyte antigen class II molecules. A novel regulation of PKC activity. J Biol Chem 1991; 266: 24169 75. | en_US |
dc.identifier.citedreference | Greer SF, Lin J, Clarke CH et al. Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45. J Biol Chem 1998; 273: 11970 9. | en_US |
dc.identifier.citedreference | Lane PJ, McConnell FM, Schieven CL et al. The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation. J Immunol 1990; 144: 3684 92. | en_US |
dc.identifier.citedreference | Scholl PR & Geha RS. MHC class II signaling in B-cell activation. Immunol Today 1994; 15: 418 22. | en_US |
dc.identifier.citedreference | Altomonte M, Simonelli C, Tirelli U et al. Signaling by HLA class II antigens on B cells [letter]. Immunol Today 1995; 16: 548. | en_US |
dc.identifier.citedreference | Truman JP, Garban F, Choqueux C et al. HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 1996; 24: 1409 15. | en_US |
dc.identifier.citedreference | Odum N, Martin PJ, Schieven GL et al. Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells. Hum Immunol 1991; 32: 85 94. | en_US |
dc.identifier.citedreference | Odum N, Yoshizumi H, Okamoto Y et al. Signal transduction by HLA class II molecules in human T cells: induction of LFA-1-dependent and independent adhesion. Hum Immunol 1992; 35: 71 84. | en_US |
dc.identifier.citedreference | Odum N, Kanner SB, Ledbetter JA et al. MHC class II molecules deliver costimulatory signals in human T cells through a functional linkage with IL-2-receptors. J Immunol 1993; 150: 5289 98. | en_US |
dc.identifier.citedreference | Spertini F, Chatila T, Geha RS. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J Immunol 1992; 149: 65 70. | en_US |
dc.identifier.citedreference | Truman JP, Ericson ML, Choqueux-Seebold CJ et al. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 1994; 6: 887 96. | en_US |
dc.identifier.citedreference | Fuleihan R, Spertini F, Geha RS et al. Role of protein kinase activation in the induction of B cell adhesion by MHC class II ligands. J Immunol 1992; 149: 1853 8. | en_US |
dc.identifier.citedreference | Mourad W, Geha RS, Chatila T. Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med 1990; 172: 1513 6. | en_US |
dc.identifier.citedreference | Rich T, Lawler SE, Lord JM et al. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains. J Immunol 1997; 159: 3792 8. | en_US |
dc.identifier.citedreference | Wade WF, Davoust J, Salamero J et al. Structural compartmentalization of MHC class II signaling function. Immunol Today 1993; 14: 539 46. | en_US |
dc.identifier.citedreference | Arthur LO, Bess JW Jr, Sowder RCd et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992; 258: 1935 8. | en_US |
dc.identifier.citedreference | Hoxie JA, Fitzharris TP, Youngbar PR et al. Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 1987; 18: 39 52. | en_US |
dc.identifier.citedreference | Orentas RJ & Hildreth JE. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retrovir 1993; 9: 1157 65. | en_US |
dc.identifier.citedreference | Rossio JL, Bess J Jr, Henderson LE et al. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res Hum Retrovir 1995; 11: 1433 9. | en_US |
dc.identifier.citedreference | Cantin R, Fortin JF, Lamontagne G et al. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol 1997; 71: 1922 30. | en_US |
dc.identifier.citedreference | Cosma A, Blanc D, Braun J, et al. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class 1 molecules. AIDS 1999; 13: 2033 42. | en_US |
dc.identifier.citedreference | Saifuddin M, Crnich C, Long T et al. Transfer of host T-cell membrane HLA-DR and CD25 to target cells by human retroviruses. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 196 202. | en_US |
dc.identifier.citedreference | Boss JM. Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997; 9: 107 13. | en_US |
dc.identifier.citedreference | Muhlethaler-Mottet A, Otten LA, Steimle V et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997; 16: 2851 60. | en_US |
dc.identifier.citedreference | Steimle V, Otten LA, Zufferey M et al. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135 46. | en_US |
dc.identifier.citedreference | Wright KL, Chin KC, Linhoff M et al. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc Natl Acad Sci USA 1998; 95: 6267 72. | en_US |
dc.identifier.citedreference | Morikawa S, Tatsumi E, Baba M et al. Two E-rosette-forming lymphoid cell lines. Int J Cancer 1978; 21: 166 70. | en_US |
dc.identifier.citedreference | Saifuddin M, Parker CJ, Peeples ME et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995; 182: 501 9. | en_US |
dc.identifier.citedreference | Chang CH, Fontes JD, Peterlin M et al. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367 74. | en_US |
dc.identifier.citedreference | Roebuck KA, Brenner DA, Kagnoff MF. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J Clin Invest 1993; 92: 1336 48. | en_US |
dc.identifier.citedreference | Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86: 2336 40. | en_US |
dc.identifier.citedreference | Ugolini S, Mondor I, Sattentau QJ. HIV-1 attachment: another look. Trends Microbiol 1999; 7: 144 9. | en_US |
dc.identifier.citedreference | Mondor I, Ugolini S, Sattentau QJ. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 1998; 72: 3623 34. | en_US |
dc.identifier.citedreference | Roebuck KA & Saifuddin M. Regulation of HIV-1 transcription [Review]. Gene Expr 1999; 8: 67 84. | en_US |
dc.identifier.citedreference | Rabbi MF, Saifuddin M, Gu DS et al. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology 1997; 233: 235 45. | en_US |
dc.identifier.citedreference | Roebuck KA, Gu DS, Kagnoff MF. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS 1996; 10: 819 26. | en_US |
dc.identifier.citedreference | Van Lint C, Amella CA, Emiliani S et al. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J Virol 1997; 71: 6113 27. | en_US |
dc.identifier.citedreference | Ostrowski MA, Chun TW, Justement SJ et al. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 1999; 73: 6430 5. | en_US |
dc.identifier.citedreference | Hazenberg MD, Stuart JW, Otto SA et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000; 95: 249 55. | en_US |
dc.identifier.citedreference | O'Brien WA, Grovit-Ferbas K, Namazi A et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86: 1082 9. | en_US |
dc.identifier.citedreference | Weissman D, Barker TD, Fauci AS. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 1996; 183: 687 92. | en_US |
dc.identifier.citedreference | Staprans SI, Hamilton BL, Follansbee SE et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182: 1727 37. | en_US |
dc.identifier.citedreference | Mahalingam M, Peakman M, Davies ET et al. T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993; 93: 337 43. | en_US |
dc.identifier.citedreference | Mahalingam M, Pozniak A, McManus TJ et al. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin Exp Immunol 1995; 102: 481 6. | en_US |
dc.identifier.citedreference | Peakman M, Mahalingam M, Pozniak A et al. Markers of immune cell activation and disease progression. Cell activation in HIV disease. Adv Exp Med Biol 1995; 374: 17 26. | en_US |
dc.identifier.citedreference | Lekutis C, Shiver JW, Liu MA et al. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J Immunol 1997; 158: 4471 7. | en_US |
dc.identifier.citedreference | Marrack P, Endres R, Shimonkevitz R et al. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J Exp Med 1983; 158: 1077 91. | en_US |
dc.identifier.citedreference | Shaw S, Goldstein G, Springer TA et al. Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the ‘avidity’ of CTL–target interaction. J Immunol 1985; 134: 3019 26. | en_US |
dc.identifier.citedreference | Nabel G & Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells [published erratum appears in Nature 1990:178]. Nature 1987; 326: 711 3. | en_US |
dc.identifier.citedreference | Saarloos MN, Sullivan BL, Czerniewski MA et al. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1. J Virol 1997; 71: 1640 3. | en_US |
dc.identifier.citedreference | Doyle C & Strominger JL. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256 9. | en_US |
dc.identifier.citedreference | Fleury SG, Croteau G, Sekaly RP. CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex. Semin Immunol 1991; 3: 177 85. | en_US |
dc.identifier.citedreference | Kinch MS, Sanfridson A, Doyle C. The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins. J Exp Med 1994; 180: 1729 39. | en_US |
dc.identifier.citedreference | Dalgleish AG, Beverley PC, Clapham PR et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763 7. | en_US |
dc.identifier.citedreference | Mann DL, Read-Connole E, Arthur LO et al. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol 1988; 141: 1131 6. | en_US |
dc.identifier.citedreference | Plaeger S, Bass HZ, Nishanian P et al. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin Immunol 1999; 90: 238 46. | en_US |
dc.identifier.citedreference | Wrightham M, Schimpf A, Pennington TH et al. HIV induces modulation of functionally important cellular antigens. Clin Exp Immunol 1991; 85: 75 79. | en_US |
dc.identifier.citedreference | Fauci AS. Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr 1993; 6: 655 62. | en_US |
dc.identifier.citedreference | Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271: 324 8. | en_US |
dc.identifier.citedreference | Kamoun M, Zerva L, Sloan S et al. Induction of HLA class II molecules on human T cells: relationship to immunoregulation and the pathogenesis of AIDS. DNA Cell Biol 1992; 11: 265 8. | en_US |
dc.identifier.citedreference | Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355 8. | en_US |
dc.identifier.citedreference | Kanazawa S, Okamoto T, Peterlin BM. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 2000; 12: 61 70. | en_US |
dc.identifier.citedreference | Saifuddin M, Roebuck KA, Chang C-H et al. Activation of HIV-1 transcription by the MHC class II transactivator. J Immunol (Cutt Edg) 2000; 164: 3941 5. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.